These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 19244128)
1. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Dallas NA; Xia L; Fan F; Gray MJ; Gaur P; van Buren G; Samuel S; Kim MP; Lim SJ; Ellis LM Cancer Res; 2009 Mar; 69(5):1951-7. PubMed ID: 19244128 [TBL] [Abstract][Full Text] [Related]
2. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy. Feng Y; Gao S; Gao Y; Wang X; Chen Z Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077 [TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor. Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357 [TBL] [Abstract][Full Text] [Related]
4. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865 [TBL] [Abstract][Full Text] [Related]
5. Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. Bose D; Zimmerman LJ; Pierobon M; Petricoin E; Tozzi F; Parikh A; Fan F; Dallas N; Xia L; Gaur P; Samuel S; Liebler DC; Ellis LM Br J Cancer; 2011 Nov; 105(11):1759-67. PubMed ID: 22045189 [TBL] [Abstract][Full Text] [Related]
6. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802 [TBL] [Abstract][Full Text] [Related]
7. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer. Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689 [TBL] [Abstract][Full Text] [Related]
8. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset. Kucerova L; Feketeova L; Kozovska Z; Poturnajova M; Matuskova M; Nencka R; Babal P Thyroid; 2014 Mar; 24(3):520-32. PubMed ID: 24073856 [TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714 [TBL] [Abstract][Full Text] [Related]
10. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785 [TBL] [Abstract][Full Text] [Related]
11. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways. Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481 [TBL] [Abstract][Full Text] [Related]
12. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines. Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007 [TBL] [Abstract][Full Text] [Related]
13. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346 [TBL] [Abstract][Full Text] [Related]
14. Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells. An J; Ha EM J Microbiol Biotechnol; 2016 Aug; 26(8):1490-503. PubMed ID: 27221111 [TBL] [Abstract][Full Text] [Related]
15. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118 [TBL] [Abstract][Full Text] [Related]
16. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer. Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer. Huynh N; Shulkes A; Baldwin G; He H Cancer Biol Ther; 2016 Aug; 17(8):813-23. PubMed ID: 27260988 [TBL] [Abstract][Full Text] [Related]